Görl, N
17  Ergebnisse:
Personensuche X
?
1

Tuberkulose: Diagnostik und Prophylaxe:

Görl, N. ; Diel, R. ; Kneitz, C.
Zeitschrift für Rheumatologie.  70 (2011)  10 - p. 853-861 , 2011
 
?
3

Kryofibrinogenämie als seltene Ursache einer systemischen V..:

Görl, N ; Kneitz, C
Belizna C, Loufrani L, Subra JF, Godin M, Jolly P, Vitecocq O, Faller B, Ghali A, Tron F, Hamidou M, Henrion D, Lévesque H, Ifrah N. A 5-year prospective follow-up study in essential cryofibrinogenemia patients. Autoimmun Rev. 2011 Jul;10(9):559-62. DOI:10.1016/j.autrev.2011.04.009.  , 2019
 
?
5

Influence of daily oral prophylactic selenium treatment on ..:

Merkord, J ; Görl, N ; Lemke, M...
https://www.excli.de/index.php/excli/article/view/104/162.  , 2017
 
?
6

MDA5-assoziierte Dermatomyositis mit interstitieller Lungen..:

Görl, N ; Kneitz, C
Chen Z, Cao M, Plana MN, Liang J, Cai H, Kuwana M, Sun L. Utility of anti-melanoma differentiation-associated gene 5 antibody measurement in identifying patients with dermatomyositis and a high risk for developing rapidly progressive interstitial lung disease: a review of the literature and a meta-analysis. Arthritis Care Res (Hoboken). 2013 Aug;65(8):1316-24. DOI:10.1002/acr.21985.  , 2016
 
?
9

Netto-Null-2050 Wegweiser - Strategische Handlungsempfehlun..:

Abetz, V ; Baetcke, L ; Ball, C...
https://www.ufz.de/index.php?en=20939&ufzPublicationIdentifier=28017.  , 2023
 
?
10

On the path to net-zero: Establishing a multi-level system ..:

Köhnke, F ; Steuri, B ; El Zohbi, J...
https://www.ufz.de/index.php?en=20939&ufzPublicationIdentifier=24736.  , 2023
 
?
 
?
12

Net-zero CO2 Germany - A retrospect from the year 2050:

Mengis, N ; Kalhori, A ; Simon, S...
https://www.ufz.de/index.php?en=20939&ufzPublicationIdentifier=25634.  , 2022
 
?
 
?
14

Net‐Zero CO2Germany—A Retrospect From the Year 2050:

Mengis, N ; Kalhori, A ; Simon, S...
info:eu-repo/semantics/altIdentifier/doi/10.1029/2021EF002324.  , 2022
 
?
 
1-15